| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
59,530,000 |
| Market
Cap: |
20.23(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.26 - $1.09 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Clene is a clinical-stage pharmaceutical company focusing on the discovery, development, and commercialization of clean-surfaced nanotechnology therapeutics. Co. is focused on addressing the unmet medical needs in two areas: first, those related to central nervous system disorders including Amyotrophic Lateral Sclerosis, Multiple Sclerosis, and Parkinson's Disease; and second, those related to COVID-19, an infectious viral respiratory disease with serious and sometimes fatal co-morbidities. In addition to the development of clean-surfaced nanocrystals, Co.'s electro-crystal-chemistry platform can produce ionic solutions of various transition elements including silver, zinc, and others.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
250,002 |
8,091,457 |
14,469,307 |
| Total Buy Value |
$0 |
$102,501 |
$6,375,915 |
$13,707,746 |
| Total People Bought |
0 |
1 |
4 |
6 |
| Total Buy Transactions |
0 |
1 |
4 |
20 |
| Total Shares Sold |
22,500 |
22,500 |
22,500 |
252,765 |
| Total Sell Value |
$8,675 |
$8,675 |
$8,675 |
$579,101 |
| Total People Sold |
1 |
1 |
1 |
4 |
| Total Sell Transactions |
1 |
1 |
1 |
5 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  General Resonance Llc |
10% Owner |
– – • |
2024-04-09 |
4 |
S |
$0.38 |
$8,675 |
D/D |
(22,500) |
15,428,212 |
|
12% |
|
| Matlin David J |
|
– • – |
2023-11-10 |
4 |
B |
$0.41 |
$102,501 |
D/D |
250,002 |
7,043,686 |
0.01 |
-1% |
|
| Kiernan Matthew |
|
– • – |
2023-09-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,540 |
|
-2% |
|
| Desai Arjun Jj |
|
– • – |
2023-09-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
16,298 |
|
-2% |
|
| Etherington Robert Dee |
Chief Executive Officer |
• • – |
2023-06-26 |
4 |
B |
$0.81 |
$20,250 |
I/I |
25,000 |
25,000 |
0.01 |
-53% |
|
| Stevens John Henry |
|
– • – |
2023-06-26 |
4 |
B |
$0.80 |
$253,164 |
D/D |
316,455 |
800,204 |
0.01 |
-53% |
|
| Ugwumba Chidozie |
Resigned as director 2/15/2023 |
– – • |
2023-06-16 |
4 |
B |
$0.80 |
$6,000,000 |
I/I |
7,500,000 |
13,018,908 |
1.5 |
-49% |
|
| Wilcox Reed N |
|
– • – |
2022-11-14 |
4 |
OE |
$0.15 |
$26,237 |
D/D |
174,912 |
575,145 |
|
- |
|
| Matlin David J |
|
– • – |
2022-11-02 |
4 |
B |
$1.01 |
$2,900,000 |
D/D |
2,871,287 |
5,293,684 |
0.01 |
25% |
|
| Ugwumba Chidozie |
|
– • – |
2022-11-02 |
4 |
B |
$1.01 |
$1,000,000 |
I/I |
990,099 |
5,518,908 |
0.01 |
25% |
|
| Gay Jonathon |
|
– • – |
2022-11-02 |
4 |
B |
$1.01 |
$1,000,000 |
I/I |
990,099 |
2,154,848 |
0.01 |
25% |
|
| Mosca Alison |
|
– • – |
2022-11-02 |
4 |
B |
$1.01 |
$800,000 |
I/I |
792,079 |
844,000 |
0.01 |
25% |
|
| Stevens John Henry |
|
– • – |
2022-11-02 |
4 |
B |
$1.01 |
$150,000 |
D/D |
148,515 |
483,749 |
0.01 |
25% |
|
| Stevens John Henry |
|
– • – |
2022-08-17 |
4 |
B |
$3.85 |
$183,499 |
D/D |
47,662 |
335,234 |
0.01 |
-75% |
|
| Etherington Robert Dee |
Chief Executive Officer |
• • – |
2022-07-18 |
4 |
AS |
$4.72 |
$110,840 |
D/D |
(23,483) |
56,593 |
|
-78% |
|
| Matlin David J |
|
– • – |
2022-06-17 |
4 |
B |
$2.51 |
$187,271 |
D/D |
74,610 |
2,422,397 |
0.01 |
-58% |
|
| Matlin David J |
|
– • – |
2022-06-16 |
4 |
B |
$2.50 |
$187,500 |
D/D |
75,000 |
2,347,787 |
0.01 |
-58% |
|
| Mortenson Mark |
Chief Science Officer |
• – – |
2022-06-16 |
4 |
AS |
$2.47 |
$50,010 |
D/D |
(20,247) |
168,759 |
|
-58% |
|
| Mosca Alison |
|
– • – |
2022-06-15 |
4 |
B |
$2.62 |
$13,100 |
D/D |
5,000 |
39,476 |
0.01 |
-58% |
|
| Matlin David J |
|
– • – |
2022-06-15 |
4 |
B |
$2.66 |
$119,700 |
D/D |
45,000 |
2,272,787 |
0.01 |
-58% |
|
| Matlin David J |
|
– • – |
2022-06-14 |
4 |
B |
$2.66 |
$135,689 |
D/D |
51,011 |
2,227,787 |
0.01 |
-60% |
|
| Matlin David J |
|
– • – |
2022-06-06 |
4 |
B |
$2.57 |
$130,222 |
D/D |
50,670 |
2,121,776 |
0.01 |
-45% |
|
| Matlin David J |
|
– • – |
2022-06-03 |
4 |
B |
$2.46 |
$24,600 |
D/D |
10,000 |
2,071,106 |
0.01 |
-41% |
|
| Matlin David J |
|
– • – |
2022-05-27 |
4 |
B |
$2.27 |
$79,450 |
D/D |
35,000 |
2,061,106 |
0.01 |
-24% |
|
| Matlin David J |
|
– • – |
2022-05-16 |
4 |
B |
$2.20 |
$400,000 |
D/D |
181,818 |
2,026,106 |
0.01 |
39% |
|
69 Records found
|
|
Page 1 of 3 |
|
|
0.01 (1.9%) 
